The prevalence of obesity and its co-morbidity factors, type 2 diabetes and metabolic syndrome have increased dramatically in almost all EU Member States.
Obesity Prevalence of obesity in EU has more than doubled over the past 20 years. Over 50% of men and women are overweight, 20% men and 23% women obese.
Diabetes Diabetes absorbs up to 10% of health care budgets in some EU countries. Diabetes is one of the most common non-communicable diseases in Europe. Upward trend: prevalence increasing by approx. 1% every 3 years.
Neurological disorders affecting child brain development and behaviour
AUTISM SPECTRUM DISORDERS (ASD) A number of recent studies show an increase in the incidence and prevalence of autism over the last 50 years. Studies in several countries show a population rate of one in 500.
ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) Attention Deficit Hyperactivity Disorder (ADHD) is now the most common neuro-developmental disorder in children in Europe. Studies in several countries show a population rate of one in 500. In the UK, 3.62% of boys and 0.85% of girls aged 4-15 are affected. Incidence rates in EU countries range from 2-10%.
Prostate cancer is the most common cancer in men in the EU representing 25% of all male new cancer cases diagnosed. 1 in 7 men in UK will develop this condition during his lifetime. All European countries (except those with high incidence already) have seen dramatically increasing incidence trends in recent years.
All EU countries are experiencing strong rises in testicular cancer. Incidence has doubled over the past 25 years. Cancer of the testes is now the most common cancer of young men, peaking at 25-30 years.
Reproductive and fertility problems, including low sperm count
By 1992, sperm quality across the European population was reported to have declined by 50% in the previous 50 years. A recent study of 26,600 men in France showed sperm count had fallen by a third between 1989 and 2005. Furthermore, a Spanish study found that even in young men, sperm concentration was falling by an average of two percent a year.
An estimated one in six couples seeks help in conceiving a child. The demand for treatment in Europe – as expressed in treatment cycles performed in European countries – has increased by 59% in the five years.
€31 billion per year in EU health savings possible from reducing exposures to hormone disrupting chemicals
Exposure to food and everyday electronic, cosmetic and plastic products containing endocrine disrupting chemicals (EDCs) may be costing up to €31 billion per year in the EU, according to a report launched today by the HEAL.
Spiralling rates of hormone-related disease may be due to exposure to hormone-mimicking synthetic chemicals found in food, drink and everyday products.
New study says if a small portion of hormone-related cancers, diabetes & obesity, and infertility could be avoided by reducing exposure to hormone disrupting chemicals, then billions in costs from these diseases and conditions could be saved.
A change in European chemicals policy could massively reduce costs associated with cases of hormone-related diseases and conditions. EU should act now.
The Chemicals Health Monitor aims to be your online source for the link between chemicals and diseases
” The Health and Environment Alliance (HEAL) has today re-launched its Chemicals Health Monitor (CHM), a revived online service consisting of a revamped website and newsletter as well as new social media tools, all available in English and German.
HEAL provides this monitoring service with the aim of improving public health by promoting support for more protective regulation of hazardous chemicals in Europe and beyond. The project encourages public health and health professional groups to use and share educational resources to inform patients and the public.
Many of the chemicals to which people are exposed daily have never been tested for their effects on human health and the environment. When studies have been done, the test results may not be publicly available. Meanwhile, more and more studies link chemical exposure to a range of specific chronic conditions. The research suggests that due to their exposure, families and individuals may be more prone to obesity and diabetes, more likely to suffer from cancer, and more likely to face infertility. Healthcare systems are struggling to cope with rising rates of these conditions.
Although EU laws set high and innovative standards, significant gaps nonetheless remain, particularly regarding the effects of multiple concurrent exposures and of long-term, cumulative exposures. The Chemicals Health Monitor provides the latest authoritative, independent information linking chemical exposure to chronic health problems, which is developed with the help of public interest expertise.
HEAL’s ultimate goal in providing such a service is to inform the public and to mobilise partnerships in support of EU policies that protect health. In particular, HEAL seeks precautionary action to prevent exposure to toxic chemicals and effective implementation of the EU chemicals law, REACH.”
Sources: HEAL Blog, Brussels, 25 March 2014 – Follow on Twitter